Degenerated nucleus pulposus cells derived exosome carrying miR-27a-3p aggravates intervertebral disc degeneration by inducing M1 polarization of macrophages.

Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155 (Electronic) Linking ISSN: 14773155 NLM ISO Abbreviation: J Nanobiotechnology Subsets: MEDLINE

Original Publication: London : BioMed Central, 2003-

Exosomes* ; Intervertebral Disc Degeneration*/genetics ; Nucleus Pulposus* ; MicroRNAs*/genetics; Animals ; Rats ; Phosphatidylinositol 3-Kinases ; Macrophages

Background: Intervertebral disc degeneration (IVDD) is a major contributor to spinal disorders. Previous studies have indicated that the infiltration of immunocytes, specifically macrophages, plays a crucial role in the advancement of IVDD. Exosomes (exo) are believed to play a significant role in intercellular communication. This study aims to investigate the role of exosomes derived from degenerated nucleus pulposus (dNPc) in the process of macrophages M1 polarization.
Methods: Nucleus pulposus (NP) tissue and nucleus pulposus cells (NPc) were collected from patients with intervertebral disc degeneration (IVDD) and idiopathic scoliosis. Immunohistochemistry analysis was performed to determine the number of M1 macrophages in NP tissue. Subsequently, exosomes derived from degenerated NP cells (dNPc-exo) and non-degenerated NP cells (nNPc-exo) were collected and co-cultured with M0 macrophages, which were induced from THP-1 cells. The M1 phenotype was assessed using western blot, flow cytometry, immunofluorescence staining, and qRT-PCR. RNA-sequencing analysis was conducted to examine the expression levels of microRNAs in the dNPc-exo and nNPc-exo groups, and qRT-PCR was performed to investigate the effect pf different microRNA to induce macrophage polarization. Furthermore, western blot and qRT-PCR were employed to demonstrate the regulatory effect of microRNAs carried by dNPc-exo on downstream target signaling pathways in macrophages. Finally, an animal model of IVDD was utilized to investigate the impact of dNPc-exo on inducing M1 polarization of macrophages and its role in the IVDD process.
Results: In this study, we observed an increase in the number of M1 macrophages as the intervertebral disc (IVD) degraded. Additionally, we discovered that dNPc releases exosomes (dNPc-exo) could promote the polarization of macrophages towards the M1 phenotype. Notably, through RNA-sequencing analysis of dNPc-exo and nNPc-exo groups, we identified miR-27a-3p as a highly expressed miRNA in the dNPc-exo group, which significantly influences the induction of M1 polarization of macrophages. And then, we discovered that dNPc-exo has the ability to transport miR-27a-3p and target the PPARγ/NFκB/PI3K/AKT signaling pathway, thereby influencing the M1 polarization of macrophages. We conducted experiments using rat model of IVDD and observed that the exosomes carrying miR-27a-3p actually induced the M1 polarization of macrophages and exacerbated the degradation of IVD.
Conclusion: In conclusion, our findings highlight the significant role of dNPc-exo in IVDD process and provide a basis for further investigation into the mechanism of IVDD and the potential of exosome-based therapy.
(© 2023. BioMed Central Ltd., part of Springer Nature.)

J Cell Physiol. 2019 Apr;234(4):4217-4231. (PMID: 30132863)
Int J Mol Sci. 2023 Apr 21;24(8):. (PMID: 37108824)
J Bone Joint Surg Am. 1995 Jan;77(1):26-31. (PMID: 7822352)
J Ethnopharmacol. 2023 Oct 5;314:116645. (PMID: 37196813)
Theranostics. 2019 May 31;9(14):4084-4100. (PMID: 31281533)
Exp Cell Res. 2022 May 1;414(1):113066. (PMID: 35231441)
Bioact Mater. 2021 Dec 21;15:29-43. (PMID: 35386360)
Biomed Pharmacother. 2020 Nov;131:110660. (PMID: 32853910)
J Bone Joint Surg Am. 2006 Apr;88 Suppl 2:10-4. (PMID: 16595436)
Eur Cell Mater. 2014 Apr 04;27:251-63; discussion 263. (PMID: 24706108)
Nat Rev Rheumatol. 2014 Jan;10(1):44-56. (PMID: 24166242)
Front Bioeng Biotechnol. 2023 May 12;11:1199939. (PMID: 37251563)
Biochim Biophys Acta Gene Regul Mech. 2023 Mar;1866(1):194885. (PMID: 36288764)
Biotechnol Adv. 2023 Sep;66:108158. (PMID: 37105240)
Phytomedicine. 2023 Jun;114:154810. (PMID: 37075623)
Front Mol Biosci. 2022 Mar 14;9:835976. (PMID: 35359595)
Front Immunol. 2022 Aug 18;13:922173. (PMID: 36059551)
J Nanobiotechnology. 2021 Sep 6;19(1):264. (PMID: 34488795)
F1000Prime Rep. 2014 Mar 03;6:13. (PMID: 24669294)
Spine J. 2018 Feb;18(2):343-356. (PMID: 29031872)
Front Cell Dev Biol. 2022 Jan 04;9:796974. (PMID: 35059401)
Pharmaceuticals (Basel). 2023 May 24;16(6):. (PMID: 37375731)
Int J Med Sci. 2020 Feb 24;17(5):685-692. (PMID: 32210719)
Nat Rev Rheumatol. 2015 Apr;11(4):243-56. (PMID: 25708497)
Int J Clin Exp Pathol. 2014 Mar 15;7(4):1293-8. (PMID: 24817926)
Osteoarthritis Cartilage. 2016 Mar;24(3):398-408. (PMID: 26455958)
Front Immunol. 2021 Dec 02;12:782891. (PMID: 34925364)
Science. 2020 Feb 7;367(6478):. (PMID: 32029601)
Int Immunopharmacol. 2021 Dec;101(Pt A):107585. (PMID: 34601333)
J Healthc Eng. 2022 Mar 7;2022:4457673. (PMID: 35295173)
Biomaterials. 2016 Mar;82:34-47. (PMID: 26741882)
Biomaterials. 2018 Apr;160:56-68. (PMID: 29396379)
Ann Transl Med. 2021 Sep;9(17):1376. (PMID: 34733928)
Ageing Res Rev. 2020 Jan;57:100978. (PMID: 31669486)
Front Pharmacol. 2022 Sep 08;13:992476. (PMID: 36160436)
Nat Rev Rheumatol. 2014 Sep;10(9):561-6. (PMID: 24914695)
Neurol Clin. 2007 May;25(2):353-71. (PMID: 17445733)
Cells. 2021 Jul 24;10(8):. (PMID: 34440650)

82002348 National Natural Science Foundation of China; 82002348 National Natural Science Foundation of China; 82002348 National Natural Science Foundation of China; 82002348 National Natural Science Foundation of China; 82002348 National Natural Science Foundation of China; 82002348 National Natural Science Foundation of China; 82002348 National Natural Science Foundation of China

Keywords: Exosome; Inflammatory regulation; Intervertebral disc degeneration; Macrophages; Nucleus pulposus

EC 2.7.1.- (Phosphatidylinositol 3-Kinases)
0 (MicroRNAs)

Date Created: 20230904 Date Completed: 20230906 Latest Revision: 20231121

20250114

PMC10478255

10.1186/s12951-023-02075-y

37667246